# EDGAR Filing Document

**Accession Number:** 0002046573
**File Stem:** 0001493152-26-021302
**Filing Date:** 2026-5
**Character Count:** 7476
**Document Hash:** 8cf7b80c2ddcfd2c2abe41c9c2997d46
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-021302.hdr.sgml**: 20260505

**ACCESSION NUMBER**: 0001493152-26-021302

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20260505

**FILED AS OF DATE**: 20260505

**DATE AS OF CHANGE**: 20260505

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Pitanium Ltd
- **CENTRAL INDEX KEY:** 0002046573
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** K3
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42669
- **FILM NUMBER:** 26943373

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 30F, GRAVITY, 29 HING YIP STREET
- **STREET 2:** KWUN TONG, KOWLOON,
- **CITY:** HONG KONG
- **PROVINCE COUNTRY:** K3
- **BUSINESS PHONE:** 00852-6206 2950

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 30F, GRAVITY, 29 HING YIP STREET
- **STREET 2:** KWUN TONG, KOWLOON,
- **CITY:** HONG KONG
- **PROVINCE COUNTRY:** K3

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington**, **D**.**C**. **20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of May 2026**

**Commission File Number**: **001**-**42669**

**PITANIUM LIMITED**

**(Registrant**'**s Name)**

**30F**, **Gravity**, **29 Hing Yip Street**,

**Kwun Tong**, **Kowloon**, **Hong Kong**

**(Address of Principal Executive Offices)**

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

**<u>CONTENTS</u>**

**Press Release**

On May 4 , 2026, Pitanium Limited (the "Company") issued a press release, which was published on its official website, announcing the gradual introduction of two new product lines under its Pitanium brand. A copy of which is furnished as Exhibit 99.1 with this Report of Foreign Private Issuer on Form 6-K.

***Forward-Looking Statements***

The press release may contain forward-looking statements. Certain statements are not historical facts, and are based on management's current view and estimates of future economic circumstances, industry conditions, company performance and financial results. These statements include, but are not limited to, statements regarding the expected launch, availability, and potential benefits of the Company's new product lines. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the Company, are intended to identify forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in such statements. These risks and uncertainties include, among others, changes in market conditions, regulatory developments, product development and commercialization risks. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.

**Update on Trading Halt of Securities and Company Responses**

Reference is made to the Company's Reports on Form 6-K furnished on October 31, 2025 and November 21, 2025, which disclosed the trading halt of the Company's securities, related information requests, and the Company's written responses thereto.

On April 20, 2026, the Company received additional information requests from The Nasdaq Stock Market (Nasdaq) for certain information and documents, and the Company submitted its written response with supporting materials to Nasdaq on May 4, 2026. As of the date of this report, the Company has responded to all comments and document requests received from the U.S. Securities and Exchange Commission (SEC), Nasdaq, Financial Industry Regulatory Authority (FINRA), as applicable. The Company continues to monitor the matter and remains committed to cooperating in a transparent and timely manner. The Company's business operations remain normal and uninterrupted as of the date of this report.

This Report on Form 6-K and the information contained herein shall be deemed to be furnished and not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

**<u>EXHIBIT INDEX</u>**

---

| | |
|:---|:---|
| **Exhibit No.** |  |
| 99.1 | [Press Release Dated May 4, 2026](ex99-1.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: May 5, 2026 | **PITANIUM LIMITED** | **PITANIUM LIMITED** |
|  | By: | */s/ Ying Yeung Wong* |
|  | Name: | Ying Yeung Wong |
|  | Title: | Chief Executive Officer and Director |

---

## Exhibit 99.1

**Exhibit 99.1**

**Pitanium's All-New Series Debut:** 

**Pi-ology and Pi-Formance Offer a New Approach for Inside-Out Care**

**HONG KONG, China, May 4, 2026 — PITAMIUM LIMITED (Nasdaq: PTNM)** introduces two major new product lines: the Pi-ology Series, which focuses on biotechnological skincare, and the Pi-Formance Series, dedicated to body function and wellness. Through the dual synergistic effect of "external care and internal health," Pitanium aims to enhance personal care and anti-aging management.

![](ex99-1_001.jpg)

(*Source: Pitanium Limited*)

**The Pi-ology Series: Biotechnological Skincare**

This series applies advanced biotechnology and ingredient fermentation techniques to the realm of skincare. Through fermentation processes, core ingredients undergo a profound transformation, offering certain benefits:

**Five-Dimensional Enhancement**: The activity, purity, stability, penetrability, and longevity of the ingredients are enhanced.

**Improved Skin Compatibility**: The fermented molecular structure is designed to support skin affinity. Nutrients are expected to reach the deeper layers of the skin with "zero rejection," exerting the purest and most highly effective skincare benefits.

**The Pi-Formance Series: Building a Healthy Constitution from Within**

The Pi-Formance Series is expected to introduce targeted supplements, including women's probiotics and hair follicle health formulas. Through internal wellness support, Pitanium aims to comprehensively fortify the body's foundation. This empowers individuals to navigate daily challenges with optimal health and vitality, while simultaneously creating a powerful synergy with our skincare lines to support overall health and complement daily routines.

By combining the skincare technology of Pi-ology with the robust physiological support of Pi-Formance, Pitanium brings together dermatological science with biological wellness. The new product lines will be rolling out soon, inviting all users to step into a new era of personal care together.

***The statements above are intended to describe product features and are not intended as medical or therapeutic claims. Results may vary among individuals.***

 ****

 ****